News
Innate Pharma S.A. is a global ... In addition, anti-KIR3DL2 mAb lacutamab is developed in advanced form of cutaneous T cell lymphomas and peripheral T cell lymphomas, and anti-NKG2A mAb ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback